Introduction: Ehlers-Danlos Syndromes (EDS) comprise a group of hereditary connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. With its diverse clinical manifestations and genetic heterogeneity, EDS poses significant challenges in diagnosis, management, and quality of life for affected individuals. The EDS market encompasses a spectrum of diagnostic tools, treatment modalities, and […]
Tag: Ehlers Danlos Syndromes Market
Back To Top